Episode Details
Back to Episodes
Personalized mRNA Vaccine for Melanoma | Madison News
Description
Moderna and Merck just dropped a bombshell: a personalized mRNA vaccine tailored to each patient’s melanoma, paired with Keytruda, slashes recurrence and spread in high-risk patients—potentially rewriting cancer treatment. With no major safety red flags and stock soaring, this breakthrough could unlock a new era of precision immunotherapy for solid tumors.
Listen in comfort:
Get a discount on a Soli Pillow: http://solipillow.com/discount/dnn.
Advertise on DNN:
advertise@thednn.ai
This is an automated, high-level news summary based on public reporting.
Report issues to feedback@thednn.ai.
View sources & latest updates:
https://sources.thednn.ai/7a91abd00d648e48